On Monday, Shares of Fitbit Inc (NYSE:FIT), added 0.04% and closed at $13.10 in the last trading session. FIT stock opened its last trade at $13.28 and after floating in a range of $12.98 to $13.31. The company’s Market capitalization is $2.86 Billion with the total Outstanding Shares of 222.15 million. During the 52-week trading session the minimum price at which share price traded, registered at $11.65 and reached to max level of $41.97. Fitbit (FIT), the leader in the connected health and fitness market, recently declared pre-sale global availability of the highly anticipated accessory collection created in partnershipwith New York design house PUBLIC SCHOOL for Fitbit Alta™. First debuted at New York Fashion Week in February 2016, the PUBLIC SCHOOL accessories blend aspirational runway fashion with edgy, urban street-style, elevating the sleek design of Alta by bringing its unique aesthetic to the device’s easily interchangeable accessory bands. Available for pre-order recently at Fitbit.com, the PUBLIC SCHOOL for Fitbit Axis Accessory Band and Type-III Paracord Bracelet will begin shipping globally in November, with additional print band designs available in 2017.
“One of my favorite things about PUBLIC SCHOOL’s designs is the range—they mix sportswear and tailoring, pair high and low with ease, and present as both upscale and edgy,” said Eugene Tong, stylist for PUBLIC SCHOOL shows and contributing fashion editor and market director, Men’s at W Magazine. “The unexpected marriage of PUBLIC SCHOOL’s aesthetic with Fitbit’s innovative technology brings that unique range of style to people in a way that will assist fit fitness into their daily lives and provide them with an exciting opportunity to coordinate technology to personal style, mood and activities.”
MannKind Corporation (NASDAQ:MNKD), subtract -6.71% and closed at $0.469 in the last trading session. MNKD stock opened its last trade at $0.50 and after floating in a range of $0.46 to $0.52. The company’s Market capitalization is $201.61 million with the total Outstanding Shares of 478.05 Billion. During the 52-week trading session the minimum price at which share price traded, registered at $0.46 and reached to max level of $3.79. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes patients in the United States. Its approved product is AFREZZA, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes.